Sandra Nieto
Family Medicine · San Antonio, TXNPI 1467580191
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 405 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AstraZeneca at 25.8% of the total. Reporting peaked in 2019 at $1,579 and has fallen 59.3% since, to $643 in 2023. Among family medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 405 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$1K
- Novo Nordisk$888
- Lilly USA, LLC$794
- Supernus Pharmaceuticals, Inc.$527
- Johnson & Johnson$256
- plus $1K from 20 others
What the payments were for
- Food & beverage$6,418100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $1,657 |
| AbbVie(2 entities) | 71 | $1,062 |
| Novo Nordisk | 77 | $888 |
| Lilly USA, LLC | 68 | $794 |
| Supernus Pharmaceuticals, Inc. | 45 | $527 |
| Johnson & Johnson | 16 | $256 |
| Boehringer Ingelheim | 11 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $197 |
| Currax Pharmaceuticals LLC | 18 | $175 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $94 |
| Sanofi-aventis U.S. LLC | 5 | $89 |
| Biohaven Pharmaceuticals, Inc. | 5 | $74 |
| Upsher-smith Laboratories LLC | 4 | $62 |
| Merck | 3 | $45 |
| Bayer | 3 | $43 |
| Avanir Pharmaceuticals, Inc. | 2 | $38 |
| Amgen | 2 | $34 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| Vivus LLC | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $21 |
| Shire North American Group Inc | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| GSK | 1 | $15 |
| Pfizer | 1 | $15 |
| Nalpropion Pharmaceuticals LLC | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,424 in reported general payments places this provider in the 90th percentile of 8,760 family medicine providers in Texas.
Other family medicine in San Antonio
- Aaron KingSan Antonio$1.1M
- Solomon PaleySan Antonio$136K
- Sarah SamreenSan Antonio$133K
- Melissa WalkerSan Antonio$53K
- Paul SaenzSan Antonio$50K
- Carlos CamposNew Braunfels$1.5M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.